Plasma p-tau181 and p-tau217 in discriminating PART, AD and other key neuropathologies in older adults

We examined whether plasma p-tau181 and p-tau217 are specific biomarkers of pathologically confirmed Alzheimer’s disease (AD). In particular, we investigated the utility of plasma p-tau for differentiating AD from primary age-related tauopathy (PART), as well as AD with mixed pathologies. Data came...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Lei, Boyle, Patricia A., Janelidze, Shorena, Petyuk, Vladislav A., Wang, Tianhao, Bennett, David A., Hansson, Oskar, Schneider, Julie A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10261204/
https://www.ncbi.nlm.nih.gov/pubmed/37031430
http://dx.doi.org/10.1007/s00401-023-02570-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10261204/
https://www.ncbi.nlm.nih.gov/pubmed/37031430
http://dx.doi.org/10.1007/s00401-023-02570-4

Ejemplares similares